追蹤
Kuan-Chiao Tseng
Kuan-Chiao Tseng
其他名字Joe K Tseng
Alnylam Pharmaceuticals
在 alnylam.com 的電子郵件地址已通過驗證
標題
引用次數
引用次數
年份
Gender differences in healthcare service utilisation 1 year before suicide: national record linkage study
CM Chang, SC Liao, HC Chiang, YY Chen, KC Tseng, YL Chau, ...
The British Journal of Psychiatry 195 (5), 459-460, 2009
442009
Travel distance and the use of inpatient care among patients with schizophrenia
KC Tseng, D Hemenway, I Kawachi, SV Subramanian, WJ Chen
Administration and Policy in Mental Health and Mental Health Services …, 2008
382008
Associations among eczema, asthma, serum immunoglobulin E and depression in adults: a population-based study.
YW Yang, KC Tseng, YH Chen, JY Yang
322010
Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B
YW Huang, CW Hsu, SN Lu, ML Yu, CW Su, WW Su, RN Chien, CS Hsu, ...
Hepatology International 14, 997-1008, 2020
312020
Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C.
SJ Hsu, ML Yu, CW Su, CY Peng, RN Chien, HH Lin, GH Lo, WW Su, ...
Journal of the Formosan Medical Association= Taiwan yi zhi 120 (3), 956-964, 2020
212020
Ropeginterferon alfa‐2b in patients with genotype 1 chronic hepatitis C: pharmacokinetics, safety, and preliminary efficacy
HH Lin, SJ Hsu, SN Lu, WL Chuang, CW Hsu, RN Chien, SS Yang, ...
JGH Open 5 (8), 929-940, 2021
202021
Rhabdomyolysis following dose increase of clozapine and combination therapy with lithium
KC Tseng, TJ Hwang
Journal of clinical psychopharmacology 29 (4), 398-399, 2009
192009
The impact of the Chi-Chi earthquake on the incidence of hospitalizations for schizophrenia and on concomitant hospital choice
KC Tseng, D Hemenway, I Kawachi, SV Subramanian, WJ Chen
Community mental health journal 46, 93-101, 2010
162010
A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C
CY Chen, WL Chuang, A Qin, WH Zhang, LY Zhu, GQ Zhang, JJ Chen, ...
JGH Open 6 (11), 782-791, 2022
152022
Family ties and the frequency of heroin use
KC Tseng, D Hemenway, I Kawachi, SV Subramanian
Journal of Substance Use 15 (1), 60-74, 2010
142010
Factors of early suicide after discharge: a national linkage study for suicide victims in Taiwan
KC Tseng, CM Chang, SC Liao, YY Chen, MB Lee
Suicide and Life-Threatening Behavior 40 (4), 353-368, 2010
92010
Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: phase I Results
JB Hong, PY Wu, A Qin, YW Huang, KC Tseng, CY Lai, WK Chan, J Fang, ...
Pharmaceutics 14 (10), 2159, 2022
42022
Oral paclitaxel and encequidar in patients with breast cancer: a pharmacokinetic, safety, and antitumor activity study
MS Dai, TC Chao, CF Chiu, YS Lu, HS Shiah, CGCA Jackson, N Hung, ...
Therapeutic Advances in Medical Oncology 15, 17588359231183680, 2023
32023
Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results. Pharmaceutics 2022, 14, 2159
JB Hong, PY Wu, A Qin, YW Huang, KC Tseng, CY Lai, WK Chan, J Fang, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
2022
治療 C 型肝炎的新選項: Ropeginterferon alfa-2b (P1101)
蔡崇偉, 賴慶輿, 王廷芳, 馬緯傑, 高宜君, 鄭兆勝, 曾冠喬, 秦小強, ...
台灣醫學 21 (6), 603-613, 2017
2017
Every-two-week ropeginterferon alfa-2b is safe with better efficacy in interferon naive patients with chronic hepatitis B virus infection: A phase 2, open-label, randomized …
YW Huang, PJ Chen, CW Hsu, SN Lu, ML Yu, CW Su, WW Su, RN Chien, ...
Hepatology 66 (6), 2017
2017
Social Determinants and Mental Health: Implications for Social Policy in Taiwan
KC Tseng
Harvard School of Public Health, 2005
2005
系統目前無法執行作業,請稍後再試。
文章 1–17